Ariaans, Gerke <br/><br/>
Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.  [electronic resource] 

 -  BMC cancer  03 2017 
 - 232 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2407 
<br/><br/><label>Standard No.: </label>10.1186/s12885-017-3230-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms--metabolism<br/>Cell Hypoxia<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Everolimus--pharmacology<br/>Female<br/>Glucose--metabolism<br/>Glycolysis<br/>Humans<br/>Metformin--pharmacology